| Cash Flow for Vertex Pharmaceuticals Inc. (VRTX) | | | | After Hours: $ 23.69 |  -1.75 (-6.88%) | Volume: 2.9 k | 4:15 PM EDT Oct 10, 2008 | | | | | | | Cash Flow | in Thousands of Dollars | | | 12/2007 | 12/2006 | 12/2005 | 12/2004 | 12/2003 | | | Net Income | (391,279) | (206,891) | (203,417) | (166,247) | (196,767) | | Depreciation & Amortization | 27,459 | 25,868 | 27,289 | 29,640 | 23,438 | | Deferred Income Taxes | - | - | - | - | - | | Operating Losses | 297 | (11,089) | 56,147 | 7,188 | 6,408 | | Extraordinary Losses | - | - | - | - | - | | | Decrease in Receivables | 31,603 | (42,328) | (8,704) | (4,567) | 1,574 | | Decrease in Inventories | - | - | - | - | - | | Decrease in Other Current Assets | - | - | - | - | (2) | | Increase in Payables | 17,382 | 9,158 | (450) | (5,646) | (2,151) | | Increase in Other Current Liabilities | 20,338 | 48,803 | (42,117) | (3,345) | 70,159 | | Decrease in Other Working Capital | (21,220) | 107,975 | - | - | (1,232) | | Other Non-Cash Items | 63,747 | 46,583 | - | - | - | | Net Cash from Continuing Operations | (252,476) | (22,475) | (172,054) | (142,160) | (97,977) | | Net Cash from Discontinued Operations | - | - | - | - | (69,646) | | Cash from Operating Activities | (252,476) | (22,475) | (172,054) | (142,160) | (167,623) | | | | Sale of Property, Plant, Equipment | - | - | - | - | - | | Sale of Short Term Investments | 755,620 | 302,265 | 243,410 | 292,351 | 593,998 | | | Purchase of Property, Plant, Equipment | (32,415) | (32,417) | (16,959) | (12,495) | (17,351) | | Acquisitions | - | - | - | - | - | | Purchase of Short Term Investments | (317,470) | (508,085) | (236,489) | (148,506) | (555,842) | | Other Investment Changes, Net | - | 29,593 | 8,306 | (23,922) | 1,633 | | Cash from Investing Activities | 405,166 | (208,471) | (1,732) | 107,428 | 119,585 | | | Issuance of Debt | - | - | 197,591 | - | 27,460 | | Issuance of Capital Stock | 31,965 | 366,035 | - | 8,742 | 11,959 | | | Repayment of Debt | (42,102) | - | - | (12,563) | (1,951) | | Repurchase of Capital Stock | - | - | - | - | - | | Payment of Cash Dividends | - | - | - | - | - | | Other Financing Charges, Net | (53) | (170) | (135) | (4,805) | - | | Cash from Financing Activities | (10,190) | 365,865 | 197,456 | (8,626) | 37,468 | | | | Effect of Exchange Rate Changes | (8) | 207 | (631) | 205 | 631 | | Net Change in Cash | 142,492 | 135,126 | 23,039 | (43,153) | (9,939) | | | Cash at Beginning of Year | 213,171 | 78,045 | 55,006 | 98,159 | 108,098 | | Cash at End of Period | 355,663 | 213,171 | 78,045 | 55,006 | 98,159 | | | |
